Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy

Atopic dermatitis (AD) is among the most common inflammatory skin diseases in children and adults in industrialized countries. Up to one-third of adults (probably a smaller proportion in childhood) suffer from moderate-to-severe AD, whose recommended treatment is usually based on systemic therapies....

Descripción completa

Detalles Bibliográficos
Autores principales: D’Erme, Angelo Massimiliano, Romanelli, Marco, Chiricozzi, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439982/
https://www.ncbi.nlm.nih.gov/pubmed/28553077
http://dx.doi.org/10.2147/DDDT.S113192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439982/
https://www.ncbi.nlm.nih.gov/pubmed/28553077
http://dx.doi.org/10.2147/DDDT.S113192

Ejemplares similares